Phytohealth Corporation(TW:4108)
NT$10.35-0.25 (-2.36%)
TW:4108
Phytohealth Corporation financials statements
NT$10.35
At close:-0.25 (-2.36%)
Phytohealth Corporation (4108) Ratios
Phytohealth Corporation Ratios
TW:4108's free cash flow for Q2 2026 was NT$-3.45M. For the 2026 fiscal year, TW:4108's free cash flow was decreased by NT$-572.00K and operating cash flow was NT$-2.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 27.41 | 24.02 | 26.13 | 25.25 | 28.78 |
| Quick Ratio | 24.67 | 21.15 | 23.21 | 22.82 | 26.19 |
| Cash Ratio | 1.88 | 0.42 | 1.09 | 1.62 | 1.67 |
| Solvency Ratio | -0.15 | -0.28 | 0.07 | -0.72 | -0.31 |
| Operating Cash Flow Ratio | -0.86 | -0.92 | -0.95 | -0.97 | -1.21 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -484.71 | -325.80 | -1018.49 |
| Net Current Asset Value | NT$ 1.20B | NT$ 1.24B | NT$ 1.42B | NT$ 1.48B | NT$ 1.54B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.26 | 1.28 | 1.22 | 1.24 | 1.25 |
| Debt Service Coverage Ratio | -161.30 | -163.75 | -45.29 | -125.57 | -52.55 |
| Interest Coverage Ratio | -464.31 | -478.15 | -353.71 | -366.86 | -235.09 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.08 | 0.09 | 0.14 | 0.15 | 0.16 |
| Net Debt to EBITDA | 1.17 | 0.08 | 1.67 | 1.13 | 1.49 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.68% | 41.68% | 41.63% | 42.10% | 46.36% |
| EBIT Margin | -81.54% | -70.46% | -45.42% | -84.46% | -56.30% |
| EBITDA Margin | -45.08% | -35.72% | -12.74% | -45.75% | -25.04% |
| Operating Profit Margin | -129.73% | -104.31% | -74.88% | -84.49% | -56.36% |
| Pretax Profit Margin | -81.82% | -70.68% | -45.63% | -84.69% | -56.54% |
| Net Profit Margin | -43.25% | -47.86% | -29.00% | -84.92% | -46.18% |
| Continuous Operations Profit Margin | -81.81% | -70.68% | -45.63% | -84.69% | -56.54% |
| Net Income Per EBT | 52.85% | 67.72% | 63.55% | 100.27% | 81.68% |
| EBT Per EBIT | 63.07% | 67.76% | 60.94% | 100.23% | 100.32% |
| Return on Assets (ROA) | -2.47% | -3.01% | -2.00% | -4.86% | -3.16% |
| Return on Equity (ROE) | -3.11% | -3.87% | -2.44% | -6.03% | -3.94% |
| Return on Capital Employed (ROCE) | -7.57% | -6.72% | -5.31% | -4.97% | -3.94% |
| Return on Invested Capital (ROIC) | -7.54% | -6.70% | -5.28% | -4.95% | -3.21% |
| Return on Tangible Assets | -2.54% | -3.10% | -2.07% | -5.04% | -3.28% |
| Earnings Yield | -2.15% | -2.20% | -1.11% | -3.03% | -1.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.70 | 3.78 | 4.51 | 5.30 | 8.28 |
| Payables Turnover | 15.92 | 11.22 | 39.80 | 13.99 | 47.22 |
| Inventory Turnover | 0.74 | 0.57 | 0.57 | 0.52 | 0.62 |
| Fixed Asset Turnover | 0.72 | 0.72 | 0.66 | 0.49 | 0.55 |
| Asset Turnover | 0.06 | 0.06 | 0.07 | 0.06 | 0.07 |
| Working Capital Turnover Ratio | 0.11 | 0.11 | 0.11 | 0.09 | 0.14 |
| Cash Conversion Cycle | 569.02 | 699.28 | 717.32 | 746.55 | 622.85 |
| Days of Sales Outstanding | 98.62 | 96.45 | 81.00 | 68.89 | 44.07 |
| Days of Inventory Outstanding | 493.33 | 635.37 | 645.49 | 703.74 | 586.51 |
| Days of Payables Outstanding | 22.93 | 32.54 | 9.17 | 26.09 | 7.73 |
| Operating Cycle | 591.96 | 731.82 | 726.49 | 772.64 | 630.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.20 | -0.25 | -0.28 | -0.30 | -0.35 |
| Free Cash Flow Per Share | -0.23 | -0.28 | -0.30 | -0.31 | -0.42 |
| Dividend Paid and CapEx Coverage Ratio | -7.16 | -9.94 | -11.16 | -37.35 | -5.16 |
| Capital Expenditure Coverage Ratio | -7.16 | -9.94 | -11.16 | -37.35 | -5.16 |
| Operating Cash Flow Coverage Ratio | -2.53 | -2.73 | -1.95 | -1.99 | -2.21 |
| Operating Cash Flow to Sales Ratio | -0.30 | -0.33 | -0.34 | -0.44 | -0.40 |
| Free Cash Flow Yield | -1.67% | -1.65% | -1.40% | -1.62% | -1.79% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -46.55 | -45.41 | -90.42 | -32.93 | -58.25 |
| Price-to-Sales (P/S) Ratio | 20.13 | 21.73 | 26.22 | 28.00 | 26.99 |
| Price-to-Book (P/B) Ratio | 1.45 | 1.75 | 2.21 | 1.99 | 2.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -59.86 | -60.48 | -71.60 | -61.63 | -55.98 |
| Price-to-Operating Cash Flow Ratio | -68.22 | -66.56 | -77.78 | -63.28 | -66.82 |
| Price-to-Earnings Growth (PEG) Ratio | 2.15 | -0.84 | 1.54 | -0.73 | 1.36 |
| Enterprise Value Multiple | -43.49 | -60.75 | -204.15 | -60.08 | -106.31 |
| Enterprise Value | 2.64B | 3.33B | 4.23B | 3.72B | 4.50B |
| EV to EBITDA | -43.49 | -60.75 | -204.15 | -60.08 | -106.31 |
| EV to Sales | 19.60 | 21.70 | 26.00 | 27.49 | 26.62 |
| EV to Free Cash Flow | -58.29 | -60.40 | -71.01 | -60.49 | -55.21 |
| EV to Operating Cash Flow | -66.43 | -66.47 | -77.15 | -62.11 | -65.90 |
| Tangible Book Value Per Share | 11.13 | 11.59 | 11.19 | 11.06 | 11.75 |
| Shareholders’ Equity Per Share | 9.33 | 9.57 | 9.82 | 9.61 | 10.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.00 | 0.18 |
| Revenue Per Share | 0.67 | 0.77 | 0.83 | 0.68 | 0.86 |
| Net Income Per Share | -0.29 | -0.37 | -0.24 | -0.58 | -0.40 |
| Tax Burden | 0.53 | 0.68 | 0.64 | 1.00 | 0.82 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.89 | 0.84 | 0.57 | 0.88 | 0.71 |
| SG&A to Revenue | 0.67 | 0.62 | 0.60 | 0.70 | 0.53 |
| Stock-Based Compensation to Revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 |
| Income Quality | 0.36 | 0.46 | 0.74 | 0.52 | 0.71 |
Currency in TWD
